Evidence map›Paper›PMID 22001912›Full record

ArticleHuman genetics2012

Rapid detection of gene mutations responsible for non-syndromic aortic aneurysm and dissection using two different methods: resequencing microarray technology and next-generation sequencing.

Haruya Sakai, Shinichi Suzuki, Takeshi Mizuguchi, Kiyotaka Imoto, Yuki Yamashita, Hiroshi Doi, Masakazu Kikuchi, Yoshinori Tsurusaki, Hirotomo Saitsu, Noriko Miyake and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of the American Heart Association · 2021
    Article
  4. Article
  5. Is there a role for biomarkers in thoracic aortic aneurysm disease?General thoracic and cardiovascular surgery · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Haruya SakaiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan.
Shinichi Suzuki
Takeshi Mizuguchi
Kiyotaka Imoto
Yuki Yamashita
Hiroshi Doi
Masakazu Kikuchi
Yoshinori Tsurusaki
Hirotomo Saitsu
Noriko Miyake
Munetaka Masuda
Naomichi Matsumoto
Yokohama City University · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic aneurysm and/or dissection (AAD) is a life-threatening condition, and several syndromes are known to be related to AAD. In this study, two new technologies, resequencing array technology (ResAT) and next-generation sequencing (NGS), were used to analyze eight genes associated with syndromic AAD in 70 patients with non-syndromic AAD. Eighteen sequence variants were detected using both ResAT and NGS. In addition one of these sequence variants was detected by ResAT only and two additional variants by NGS only. Three of the 18 variants are likely to be pathogenic (in 4.3% of AAD patients and in 8.6% of a subset of patients with thoracic AAD), highlighting the importance of genetic analysis in non-syndromic AAD. ResAT and NGS similarly detected most, but not all, of the variants. Resequencing array technology was a rapid and efficient method for detecting most nucleotide substitutions, but was unable to detect short insertions/deletions, and it is impractical to update custom arrays frequently. Next-generation sequencing was able to detect almost all types of mutation, but requires improved informatics methods.

Indexed as

MutationActinsAdultAgedAged, 80 and overAmino Acid SequenceAortic AneurysmAortic Aneurysm, ThoracicAortic DissectionCollagen Type IIIFemaleFibrillinsGenetic Predisposition to DiseaseGlucose Transport Proteins, FacilitativeHumansMaleACTA2 protein, humanActinsCOL3A1 protein, humanCollagen Type IIIFibrillinsGlucose Transport Proteins, FacilitativeMicrofilament ProteinsMYH11 protein, humanMyosin Heavy ChainsPLOD1 protein, humanProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type IISLC2A10 protein, human

Identifiers

PMID22001912
OpenAlexW2052974907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.